Samuel Joseph Daniels - AstraZeneca | 人才画像

基本信息

Career Trajectory

Bio

Experienced Researcher working with neo-epitope biomarkers of extracellular matrix components and their clinical application within fibrotic diseases, primarily hepatic diseases.

Research Interests

Papers共 28 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

Design and Rationale for a Global Novel Non-Invasive Screening Observational Study Using Genetics and Non-Invasive Methodologies to Identify At-Risk MASLD Participants: the ALIGN Study

Samuel J. Daniels,Karin Nelander, John Eriksson,Lutz Jermutus, Jelena Saillard, Stephanie Oyesola,Federica Tavaglione,Marco Arrese, Alma Laura Ladron de Guevara,Umberto Vespasiani-Gentilucci,Naim Alkhouri,Jenny E. Blau

CONTEMPORARY CLINICAL TRIALS COMMUNICATIONS (2025)

Cited0Views0WOSBibtex

Safety, Tolerability, and Pharmacodynamics of AZD3366 (optimized Human CD39L3 Apyrase) Alone and in Combination with Ticagrelor and Acetylsalicylic Acid: A Phase 1, Randomized, Placebo‐Controlled Study

Dimitris Kardassis,Ann-Charlotte Egnell,Magnus Astrand,Samuel J. Daniels,Carl Whatling,Ola Fjellstrom,Anders Gabrielsen

Journal of the American Heart Associationno. 11 (2024)

Cited0Views0WOSBibtex

WED-270 Clinical Profile of Patients Considered At-Risk for MASH with Fibrosis Identified Through an Ongoing Global Screening Program with Genetics

Samuel Daniels,Karin Nelander, John Eriksson, Jelena Saillard,Lutz Jermutus,Federica Tavaglione, Joao-Filipe Raposo,Marco Arrese, Alma Laura Ladron de Guevara,Umberto Vespasiani Gentilucci,Naim Alkhouri,Jenny Blau

Journal of Hepatology (2024): S535-S536

Cited0Views0Bibtex

Safety and Efficacy of Novel Incretin Co-agonist Cotadutide in Biopsy-proven Non-cirrhotic MASH with Fibrosis

Sudha S. Shankar,Samuel J. Daniels,Darren Robertson,Janeli Sarv,Jose Sanchez, Debra Carter,Lutz Jermutus,Benjamin Challis,Arun J. Sanyal

Clinical Gastroenterology and Hepatology (2024)

Cited2Views0WOSBibtex

Safety and Pharmacokinetics of AZD9550, a GLP-1R/GCGR Dual Agonist, in a First-in-Human Study

Petra Sulentic,Sarah Will,Samuel Daniels, Sivaneswary Genapathy,Jacqueline Naylor, April Barbour,Hongtao Yu, Simina Boca, Elin Carlsson, Sven Gopel,David Hornigold,Stephanie Oldham,Darren Robertson,Lutz Jermutus, Mahssa Karimi,Lars Hansen

OBESITY (2024): 161-162

Cited0Views0Bibtex

PERFORMANCE OF NON-INVASIVE BIOMARKERS FOR THE DETECTION OF ADVANCED LIVER FIBROSIS IN BIOPSY CONFIRMED NASH PATIENTS ENROLLED IN PROXMO PHASE 2a

Samuel J. Daniels,Darren Robertson,Jose Sanchez,Janeli Sarv,Benjamin Challis,Arun J. Sanyal,Sudha S. Shankar

HEPATOLOGY（2022）

Cited0Views0Bibtex

Changes in Hepatic Fat Fraction As Assessed by MRI-PDFF Are Correlated with Changes in Markers of Hepatic Inflammation, Disease Activity and Fibrosis in Biopsy-Proven Non-Cirrhotic NASH with Fibrosis

Samuel Daniels,Darren Robertson,Jose Sanchez,Janeli Sarv,Antonio Manzur,Lutz Jermutus,Arun Sanyal,Benjamin Challis,Sudha Shankar

JOURNAL OF HEPATOLOGY（2022）

Cited0Views0Bibtex

Stage-dependent Expression of Fibrogenic Markers in Alcohol-Related Liver Disease

Mia Dahl Sorensen,Maja Thiele,Aleksander Krag,Samuel Joseph Daniels,Diana Julie Leeming,Morten Karsdal,Sonke Detlefsen

Pathology - Research and Practice（2022）

Cited9Views0WOSBibtex

Safety, Pharmacokinetics, and Pharmacodynamics of AZD3366 Alone and in Combination with Aspirin and Ticagrelor in Healthy Subjects

Dimitris Kardassis,Ann-Charlotte Egnell,Magnus Astrand,Samuel J. Daniels, Celeste Frickleton,Carl Whatling,Ola Fjellstrom,Anders Gabrielsen

CIRCULATION（2022）

Cited0Views0Bibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn